Dr Reddy’s and TR-Pharm in agreement

By: |
March 11, 2016 3:33 PM

TR-Pharm will manufacture the drug substance and drug product upon completion of its facility investment in Turkey

TR-Pharm will manufacture the drug substance and drug product upon completion of its facility investment in Turkey

Dr Reddy’s and TR-Pharm entered into a strategic collaboration agreement for manufacture and commercialization of a portfolio of biosimilar drugs in Turkey.

Dr Reddy’s Laboratories and TR-Pharm announced a strategic collaboration agreement involving three biosimilar products. A total of three products will be registered and subsequently commercialised as a part of this agreement by TR-Pharm in Turkey. TR-Pharm will also manufacture the drug substance and drug product upon completion of its facility investment.

TR-Pharm has begun laying out the groundwork for the technology transfer. This collaboration will be an important component of TR-Pharm’s ongoing biological product development and manufacturing business in the region. The partnership will also enable Dr Reddy’s to widen the global footprint of its biosimilar business.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.